|
Volumn 23, Issue 3, 1996, Pages 303-309
|
A randomized controlled study of post-operative adjuvant therapy in non- small cell lung cancer
a a a a a a a a a a a a a a a a a |
Author keywords
Immunochemotherapy; Non small cell lung cancer; Randomized trial
|
Indexed keywords
CISPLATIN;
PICIBANIL;
UFT;
VINDESINE;
ARTICLE;
CANCER COMBINATION CHEMOTHERAPY;
CANCER IMMUNOTHERAPY;
CANCER SURGERY;
CANCER SURVIVAL;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
HUMAN;
LUNG NON SMALL CELL CANCER;
MAJOR CLINICAL STUDY;
POSTOPERATIVE CARE;
RANDOMIZED CONTROLLED TRIAL;
ADULT;
AGED;
ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS;
CARCINOMA, NON-SMALL-CELL LUNG;
CHEMOTHERAPY, ADJUVANT;
CISPLATIN;
COMBINED MODALITY THERAPY;
DRUG COMBINATIONS;
FEMALE;
HUMANS;
JAPAN;
LUNG NEOPLASMS;
MALE;
MIDDLE AGED;
PICIBANIL;
PROSPECTIVE STUDIES;
SURVIVAL RATE;
TEGAFUR;
URACIL;
VINDESINE;
|
EID: 9044225146
PISSN: 03850684
EISSN: None
Source Type: Journal
DOI: None Document Type: Article |
Times cited : (3)
|
References (0)
|